Most Popular
-
1
Controversial US YouTuber faces travel ban, police investigation
-
2
Pyongyang to bolster readiness against nuclear retaliation: Choe
-
3
SK Innovation becomes Asia-Pacific's largest energy firm after merger
-
4
Korean serial killer 'haunted by victims' ghosts' in prison, TV show reveals
-
5
Yoon's approval rating falls to 19%, all-time low: survey
-
6
No typhoons recorded in S. Korea for the first time in 7 years
-
7
[Robert Fouser] Accepting migrants in South Korea
![[Robert Fouser] Accepting migrants in South Korea](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/10/31/20241031050896_0.jpg&u=)
-
8
Samsung CEO calls for unrivaled technological leadership
-
9
Babymonster showcases YG-style hip hop with 1st LP ‘Drip’
-
10
Allies say 1953 mutual defense treaty extends to cyber, space threats
![[Robert Fouser] Accepting migrants in South Korea](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/10/31/20241031050896_0.jpg&u=)
SK Networks Co., the general trading arm of South Korean conglomerate SK Group, said Friday it has invested $20 million in a US biotech startup specializing in making alternative leather.
SK Networks took part in a round of $126 million funding for MycoWorks, a Silicon Valley-based biomaterials company, and it is the largest amount among the strategic investors, SK said in a press release.
MycoWorks owns technologies that produce leather-like fabric from engineered mycelium, a biomaterial made out of mushrooms. The company has also partnered up with Hermes and a number of other major global luxury brands.
The two companies also signed a separate contract to cooperate on the development of new materials, production expansion and building a sales network.
Bio business is one of SK's four core areas it has been expanding as its future growth drivers, including biopharmaceuticals and biodegradable materials. (Yonhap)
SK Networks took part in a round of $126 million funding for MycoWorks, a Silicon Valley-based biomaterials company, and it is the largest amount among the strategic investors, SK said in a press release.
MycoWorks owns technologies that produce leather-like fabric from engineered mycelium, a biomaterial made out of mushrooms. The company has also partnered up with Hermes and a number of other major global luxury brands.
The two companies also signed a separate contract to cooperate on the development of new materials, production expansion and building a sales network.
Bio business is one of SK's four core areas it has been expanding as its future growth drivers, including biopharmaceuticals and biodegradable materials. (Yonhap)
![[Herald Review] ‘Amazon Bullseye,’ motley comedy of forced empathy, outdated wordplay](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/11/01/20241101050706_0.jpg&u=20241101194716)
